The role of bone‐modifying agents in myeloma bone disease
ABSTRACT Bone disease is common in patients with multiple myeloma (MM), which manifests as bone pain and skeletal‐related events (SREs) such as pathological fractures and spinal cord compression. Myeloma bone disease (MBD) can adversely affect the quality of life of patients and have negative effect...
| Published in: | JBMR Plus |
|---|---|
| Main Authors: | , , |
| Format: | Article |
| Language: | English |
| Published: |
Oxford University Press
2021-08-01
|
| Subjects: | |
| Online Access: | https://doi.org/10.1002/jbm4.10518 |